{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T08:27:29Z","timestamp":1787128049104,"version":"build-2736575974"},"reference-count":339,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>In 1909, Paul Ehrlich first suggested that the immune system is critical for suppressing carcinogenesis and cancer growth, which led to the introduction of cancer immunosurveillance by Sir MacFarlane Burnet in 1960. Burnet\u2019s cancer immunosurveillance was further supported and elaborated by Thomas Lewis in 1982, who noted, for example, the limitations of investigating cancer immunosurveillance in available experimental models, except for virus-induced cancers. The concept of cancer immunosurveillance in 2001 was revised to cancer immunoediting (the immunoediting term was introduced by Dr. Rober Schreiber), based on findings that the immune system not only controls tumorigenesis and tumor growth but also tumor quality\/grade or immunogenicity. Advances in immunology, including the identification of target organs and the local immune system, and the identification of novel innate immune cells regulating the adaptive immune response, have further advanced the understanding of cancer immunosurveillance and immunoediting. The current article discusses the evolution of the cancer immunosurveillance hypothesis into cancer immunoediting. At the time of the introduction of cancer immunoediting, the direct role of dendritic cells (DCs) in tumor immunity and immunoediting was not much explored. Similarly, the concept of tumor-associated macrophages (TAMs) and their role in cancer immunosurveillance and immunoediting was not much studied. The current article discusses the evolution of DCs and TAMs in the context of tumor immunity, cancer immunoediting, and immunotherapies specifically targeting these innate immune cells.<\/jats:p>","DOI":"10.3390\/cancers18162672","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T10:22:52Z","timestamp":1787048572000},"page":"2672","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["25 Years of Cancer Immunoediting: Dendritic Cells and Macrophages Filled the Missing Gap"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9741-3597","authenticated-orcid":false,"given":"Vijay","family":"Kumar","sequence":"first","affiliation":[{"name":"Department of Surgery, Laboratory of Tumor Immunology and Immunotherapy, Medical Education Building-C, Morehouse School of Medicine, 720 Westview Drive, Atlanta, GA 30310, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Stewart IV","sequence":"additional","affiliation":[{"name":"Department of Surgery, Laboratory of Tumor Immunology and Immunotherapy, Medical Education Building-C, Morehouse School of Medicine, 720 Westview Drive, Atlanta, GA 30310, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41392-024-02050-5","article-title":"Tissue-resident immune cells: From defining characteristics to roles in diseases","volume":"10","author":"Li","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.cell.2018.03.013","article-title":"Beyond Host Defense: Emerging Functions of the Immune System in Regulating Complex Tissue Physiology","volume":"173","author":"Rankin","year":"2018","journal-title":"Cell"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.immuni.2023.05.001","article-title":"Regulation of systemic metabolism by tissue-resident immune cell circuits","volume":"56","author":"Li","year":"2023","journal-title":"Immunity"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"eadd1967","DOI":"10.1126\/sciimmunol.add1967","article-title":"Resident tissue macrophages: Key coordinators of tissue homeostasis beyond immunity","volume":"9","author":"Zhao","year":"2024","journal-title":"Sci. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1146\/annurev-immunol-042617-053214","article-title":"Tissue-Resident T Cells and Other Resident Leukocytes","volume":"37","author":"Masopust","year":"2019","journal-title":"Annu. Rev. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1146\/annurev-immunol-093019-112809","article-title":"Tissue-Resident Immune Cells in Humans","volume":"40","author":"Gray","year":"2022","journal-title":"Annu. Rev. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1089\/vim.2019.0141","article-title":"Resident Memory B Cells","volume":"33","author":"Allie","year":"2020","journal-title":"Viral Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"aaf1098","DOI":"10.1126\/science.aaf1098","article-title":"Trained immunity: A program of innate immune memory in health and disease","volume":"352","author":"Netea","year":"2016","journal-title":"Science"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41581-022-00633-5","article-title":"Trained immunity\u2014Basic concepts and contributions to immunopathology","volume":"19","author":"Ochando","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_10","unstructured":"Bradshaw, R.A., and Stahl, P.D. (2016). Dendritic Cells. Encyclopedia of Cell Biology, Academic Press."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e70071","DOI":"10.1111\/imr.70071","article-title":"Dendritic Cell Organization and Function in Innate and Adaptive Immune Defense Within Lymph Nodes","volume":"337","author":"Huang","year":"2026","journal-title":"Immunol. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.cell.2025.11.027","article-title":"Dendritic cells regulate the innate-adaptive balance in lymph nodes for optimal host defense","volume":"189","author":"Huang","year":"2026","journal-title":"Cell"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41392-025-02124-y","article-title":"Tissue macrophages: Origin, heterogenity, biological functions, diseases and therapeutic targets","volume":"10","author":"Guan","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/s41586-023-06002-x","article-title":"Physiology and diseases of tissue-resident macrophages","volume":"618","author":"Lazarov","year":"2023","journal-title":"Nature"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41577-023-00848-y","article-title":"Tissue-specific macrophages: How they develop and choreograph tissue biology","volume":"23","author":"Mass","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.immuni.2014.06.013","article-title":"Origin and Functions of Tissue Macrophages","volume":"41","author":"Epelman","year":"2014","journal-title":"Immunity"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/ni.2419","article-title":"Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages","volume":"13","author":"Gautier","year":"2012","journal-title":"Nat. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/35074122","article-title":"IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity","volume":"410","author":"Shankaran","year":"2001","journal-title":"Nature"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: From immunosurveillance to tumor escape","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.immuni.2004.07.017","article-title":"The immunobiology of cancer immunosurveillance and immunoediting","volume":"21","author":"Dunn","year":"2004","journal-title":"Immunity"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: Integrating immunity\u2019s roles in cancer suppression and promotion","volume":"331","author":"Schreiber","year":"2011","journal-title":"Science"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1136\/bmj.1.5022.779","article-title":"Cancer; a biological approach. I. The processes of control","volume":"1","author":"Burnet","year":"1957","journal-title":"Br. Med. J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/bmj.1.5023.841","article-title":"Cancer: A biological approach. III. Viruses associated with neoplastic conditions. IV. Practical applications","volume":"1","author":"Burnet","year":"1957","journal-title":"Br. Med. J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1600-065X.1971.tb00461.x","article-title":"Immunological Surveillance in Neoplasia","volume":"7","author":"Burnet","year":"1971","journal-title":"Immunol. Rev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1600-065X.1976.tb00189.x","article-title":"The Concept of Immunological Surveillance against Neoplasia","volume":"28","year":"1976","journal-title":"Immunol. Rev."},{"key":"ref_26","first-page":"329","article-title":"On immunosurveillance in human cancer","volume":"55","author":"Thomas","year":"1982","journal-title":"Yale J. Biol. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1126\/science.183.4124.534","article-title":"Tumor development after 3-methylcholanthrene in immunologically deficient athymic-nude mice","volume":"183","author":"Stutman","year":"1974","journal-title":"Science"},{"key":"ref_28","first-page":"353","article-title":"Chemical carcinogenesis in nude mice: Comparison between nude mice from homozygous matings and heterozygous matings and effect of age and carcinogen dose","volume":"62","author":"Stutman","year":"1979","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_29","first-page":"129","article-title":"Spontaneous tumors in nude mice: Effect of the viable yellow gene","volume":"47","author":"Stutman","year":"1979","journal-title":"Exp. Cell Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/228620a0","article-title":"Cooperation of Immune Lymphoid Cells with Macrophages in Tumour Immunity","volume":"228","author":"Evans","year":"1970","journal-title":"Nature"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/bjc.1974.233","article-title":"Lymphoreticular infiltration in human tumours: Prognostic and biological implications: A review","volume":"30","author":"Underwood","year":"1974","journal-title":"Br. J. Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0065-230X(08)60724-1","article-title":"Some Recent Work on Tumor Immunity","volume":"Volume 4","author":"Greenstein","year":"1956","journal-title":"Advances in Cancer Research"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Yona, S., and Gordon, S. (2015). From the Reticuloendothelial to Mononuclear Phagocyte System\u2014The Unaccounted Years. Front. Immunol., 6.","DOI":"10.3389\/fimmu.2015.00328"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1126\/science.176.4031.170","article-title":"The immune reaction as a stimulator of tumor growth","volume":"176","author":"Prehn","year":"1972","journal-title":"Science"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0167-5699(83)90125-1","article-title":"T-cell function and specificity in athymic mice","volume":"4","author":"Hunig","year":"1983","journal-title":"Immunol. Today"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1084\/jem.149.6.1460","article-title":"The in vitro generation and sustained culture of nude mouse cytolytic T-lymphocytes","volume":"149","author":"Gillis","year":"1979","journal-title":"J. Exp. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.4049\/jimmunol.138.11.3873","article-title":"The composition of the T cell receptor repertoire in nude mice","volume":"138","author":"Maleckar","year":"1987","journal-title":"J. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/1074-7613(94)90087-6","article-title":"Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors","volume":"1","author":"Dighe","year":"1994","journal-title":"Immunity"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1084\/jem.192.5.755","article-title":"Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma","volume":"192","author":"Smyth","year":"2000","journal-title":"J. Exp. Med."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Chen, J., Liao, S., Xiao, Z., Pan, Q., Wang, X., Shen, K., Wang, S., Yang, L., Guo, F., and Liu, H.F. (2022). The development and improvement of immunodeficient mice and humanized immune system mouse models. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1007579"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"6166","DOI":"10.4049\/jimmunol.164.12.6166","article-title":"M-1\/M-2 macrophages and the Th1\/Th2 paradigm","volume":"164","author":"Mills","year":"2000","journal-title":"J. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/0092-8674(92)90029-C","article-title":"RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement","volume":"68","author":"Shinkai","year":"1992","journal-title":"Cell"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2567.2007.02587.x","article-title":"Cancer immunoediting from immune surveillance to immune escape","volume":"121","author":"Kim","year":"2007","journal-title":"Immunology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.semcancer.2007.06.009","article-title":"Tumor immunoediting and immunosculpting pathways to cancer progression","volume":"17","author":"Reiman","year":"2007","journal-title":"Semin. Cancer Biol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/PPO.0000000000000005","article-title":"Cancer immunosurveillance and immunoediting by natural killer cells","volume":"19","author":"Gross","year":"2013","journal-title":"Cancer J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.smim.2017.08.002","article-title":"Natural killer cell-mediated immunosurveillance of human cancer","volume":"31","author":"Malmberg","year":"2017","journal-title":"Semin. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1385\/IR:32:1-3:231","article-title":"Interferon-gamma and cancer immunoediting","volume":"32","author":"Dunn","year":"2005","journal-title":"Immunol. Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/nri1961","article-title":"Interferons, immunity and cancer immunoediting","volume":"6","author":"Dunn","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e143296","DOI":"10.1172\/JCI143296","article-title":"Interferons in cancer immunoediting: Sculpting metastasis and immunotherapy response","volume":"131","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41577-021-00566-3","article-title":"Interferon-\u03b3: Teammate or opponent in the tumour microenvironment?","volume":"22","author":"Gocher","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41568-026-00915-1","article-title":"Striking the right balance with type I interferon signalling in cancer","volume":"26","author":"Chadwick","year":"2026","journal-title":"Nat. Rev. Cancer"},{"key":"ref_52","unstructured":"Bhat, K.H. (2019). Macrophages: The Potent Immunoregulatory Innate Immune Cells. Macrophage Activation-Biology and Disease, IntechOpen."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/41131","article-title":"A human homologue of the Drosophila Toll protein signals activation of adaptive immunity","volume":"388","author":"Medzhitov","year":"1997","journal-title":"Nature"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/SQB.1989.054.01.003","article-title":"Approaching the asymptote? Evolution and revolution in immunology","volume":"54","author":"Janeway","year":"1989","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.immuni.2009.06.004","article-title":"Approaching the Asymptote: 20 Years Later","volume":"30","author":"Medzhitov","year":"2009","journal-title":"Immunity"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/164_2021_568","article-title":"Toll-like Receptors (TLRs) in Health and Disease: An Overview","volume":"Volume 276","author":"Kumar","year":"2022","journal-title":"Toll-like Receptors in Health and Disease"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.intimp.2018.03.002","article-title":"Toll-like receptors in immunity and inflammatory diseases: Past, present, and future","volume":"59","author":"Kumar","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"ref_58","first-page":"52","article-title":"Going, Toll-like receptors in skin inflammation and inflammatory diseases","volume":"20","author":"Kumar","year":"2021","journal-title":"EXCLI J."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jneuroim.2019.03.012","article-title":"Toll-like receptors in the pathogenesis of neuroinflammation","volume":"332","author":"Kumar","year":"2019","journal-title":"J. Neuroimmunol."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Kumar, V. (2024). Toll-like Receptors in Immunity and Inflammation. Thirty Years Since the Discovery of Toll-like Receptors, IntechOpen.","DOI":"10.5772\/intechopen.1003992"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/164_2021_543","article-title":"Toll-like Receptors in Adaptive Immunity","volume":"Volume 276","author":"Kumar","year":"2022","journal-title":"Toll-like Receptors in Health and Disease"},{"key":"ref_62","first-page":"1","article-title":"The concept of immunological surveillance","volume":"Volume 13","author":"Burnet","year":"1970","journal-title":"Immunological Aspects of Neoplasia"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000386015","article-title":"Thymic function and carcinogenesis","volume":"Volume 9","author":"Ting","year":"1967","journal-title":"Progress in Experimental Tumor Research"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1084\/jem.191.4.661","article-title":"Differential tumor surveillance by natural killer (NK) and NKT cells","volume":"191","author":"Smyth","year":"2000","journal-title":"J. Exp. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1034\/j.1600-0528.2002.00014h.x","article-title":"Regulation and antimetastatic functions of liver-associated natural killer cells","volume":"174","author":"Wiltrout","year":"2000","journal-title":"Immunol. Rev."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/82698","article-title":"NKT cells and tumor immunity--a double-edged sword","volume":"1","author":"Smyth","year":"2000","journal-title":"Nat. Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/intimm\/5.11.1383","article-title":"Induction of IFN-\u03b3 in macrophages by lipopolysaccharide","volume":"5","author":"Fultz","year":"1993","journal-title":"Int. Immunol."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Kanevskiy, L.M., Telford, W.G., Sapozhnikov, A.M., and Kovalenko, E.I. (2013). Lipopolysaccharide induces IFN-\u03b3 production in human NK cells. Front. Immunol., 4.","DOI":"10.3389\/fimmu.2013.00011"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.3892\/mmr.2017.6983","article-title":"LPS enhances TLR4 expression and IFN-\u03b3 production via the TLR4\/IRAK\/NF-\u03baB signaling pathway in rat pulmonary arterial smooth muscle cells","volume":"16","author":"Wang","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3892\/etm.2022.11283","article-title":"Relationship of interferon regulator factor 5 and interferon-\u03b3 with missed abortion","volume":"23","author":"Herkiloglu","year":"2022","journal-title":"Exp. Ther. Med."},{"key":"ref_71","unstructured":"Yasuda, K., Shukla, P., Bonegio, R.G., and Rifkin, I. (2016). IFN Regulatory Factor-5 Signaling Increases IFN-Gamma Production and Suppresses IL-2 Production from CD4+ T Cells, and Controls IgG Production in B Cells. Arthiritis Rheumatol., 68."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"9380","DOI":"10.1038\/s41598-019-45260-6","article-title":"Macrophage migration inhibitory factor regulates TLR4 expression and modulates TCR\/CD3-mediated activation in CD4+ T lymphocytes","volume":"9","author":"Roger","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1084\/jem.184.5.1781","article-title":"Decreased tumor surveillance in perforin-deficient mice","volume":"184","author":"Ossendorp","year":"1996","journal-title":"J. Exp. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1469-445X.2000.02097.x","article-title":"The role of perforin in infections and tumour surveillance","volume":"85","author":"Hengartner","year":"2000","journal-title":"Exp. Physiol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1126\/science.1063916","article-title":"Regulation of cutaneous malignancy by gammadelta T cells","volume":"294","author":"Girardi","year":"2001","journal-title":"Science"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/00000658-200105000-00005","article-title":"Interferon regulatory factor expression in human breast cancer","volume":"233","author":"Doherty","year":"2001","journal-title":"Ann. Surg."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1089\/10799900360708623","article-title":"The role of interferon regulatory factor-1 and interferon regulatory factor-2 in IFN-gamma growth inhibition of human breast carcinoma cell lines","volume":"23","author":"Yim","year":"2003","journal-title":"J. Interferon Cytokine Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1359-6101(97)00019-1","article-title":"The growing family of interferon regulatory factors","volume":"8","author":"Nguyen","year":"1997","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1016\/j.immuni.2022.10.020","article-title":"The transcription factor IRF2 drives interferon-mediated CD8+ T cell exhaustion to restrict anti-tumor immunity","volume":"55","author":"Lukhele","year":"2022","journal-title":"Immunity"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.immuni.2026.05.005","article-title":"Immunoediting restricts clonal neoantigens in primary, treatment-naive human tumors","volume":"59","author":"Borden","year":"2026","journal-title":"Immunity"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1146\/annurev.immunol.22.012703.104803","article-title":"The three Es of cancer immunoediting","volume":"22","author":"Dunn","year":"2004","journal-title":"Annu. Rev. Immunol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ccell.2023.02.018","article-title":"Immune determinants of the pre-metastatic niche","volume":"41","author":"Patras","year":"2023","journal-title":"Cancer Cell"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e22355","DOI":"10.4161\/onci.22355","article-title":"Hypoxia-driven immunosuppression contributes to the pre-metastatic niche","volume":"2","author":"Sceneay","year":"2013","journal-title":"Oncoimmunology"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/s41568-024-00752-0","article-title":"Cancer-induced systemic pre-conditioning of distant organs: Building a niche for metastatic cells","volume":"24","author":"Rabas","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF00049477","article-title":"\u2018Seed and soil\u2019 revisited: Mechanisms of site-specific metastasis","volume":"1","author":"Hart","year":"1982","journal-title":"Cancer Metastasis Rev."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s12307-009-0025-8","article-title":"The tumor microenvironment: The making of a paradigm","volume":"2","author":"Witz","year":"2009","journal-title":"Cancer Microenviron."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(00)49915-0","article-title":"The Distribution of Secondary Growths in Cancer of the Breast","volume":"133","author":"Paget","year":"1889","journal-title":"Lancet"},{"key":"ref_88","first-page":"98","article-title":"The distribution of secondary growths in cancer of the breast. 1889","volume":"8","author":"Paget","year":"1989","journal-title":"Cancer Metastasis Rev."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2005.12.005","article-title":"The tumor microenvironment in the post-PAGET era","volume":"242","author":"Witz","year":"2006","journal-title":"Cancer Lett."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.suronc.2011.09.001","article-title":"The tumor microenvironment","volume":"21","author":"Weber","year":"2012","journal-title":"Surg. Oncol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","article-title":"The tumor microenvironment","volume":"30","author":"Anderson","year":"2020","journal-title":"Curr. Biol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-3-030-37184-5_2","article-title":"Fibroblasts in the Tumor Microenvironment","volume":"1234","author":"Truffi","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-022-00894-z","article-title":"Intimate communications within the tumor microenvironment: Stromal factors function as an orchestra","volume":"30","author":"Cheng","year":"2023","journal-title":"J. Biomed. Sci."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s12272-016-0787-8","article-title":"Inflammatory fibroblasts in cancer","volume":"39","author":"Lim","year":"2016","journal-title":"Arch. Pharmacal Res."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Spaeth, E.L., Dembinski, J.L., Sasser, A.K., Watson, K., Klopp, A., Hall, B., Andreeff, M., and Marini, F. (2009). Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0004992"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/ijc.11542","article-title":"The fibroblast: Sentinel cell and local immune modulator in tumor tissue","volume":"108","author":"Silzle","year":"2004","journal-title":"Int. J. Cancer"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","article-title":"Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: New findings and future perspectives","volume":"20","author":"Mao","year":"2021","journal-title":"Mol. Cancer"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41586-024-08439-0","article-title":"Immune evasion through mitochondrial transfer in the tumour microenvironment","volume":"638","author":"Ikeda","year":"2025","journal-title":"Nature"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Kumar, V., and Stewart, J.H.t. (2023). Immunometabolic reprogramming, another cancer hallmark. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1125874"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","article-title":"Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate","volume":"21","author":"Ward","year":"2012","journal-title":"Cancer Cell"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ccell.2023.01.009","article-title":"Metabolic programming and immune suppression in the tumor microenvironment","volume":"41","author":"Arner","year":"2023","journal-title":"Cancer Cell"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Zhang, X., Liu, D., Yin, S., Gao, Y., Li, X., and Wu, G. (2025). Metabolism and epigenetics in cancer: Toward personalized treatment. Front. Endocrinol., 16.","DOI":"10.3389\/fendo.2025.1530578"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/s12276-023-01020-1","article-title":"Metabolic reprogramming and epigenetic modifications in cancer: From the impacts and mechanisms to the treatment potential","volume":"55","author":"Xu","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41392-023-01480-x","article-title":"Epigenetic regulation in the tumor microenvironment: Molecular mechanisms and therapeutic targets","volume":"8","author":"Yang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nrc3130","article-title":"A decade of exploring the cancer epigenome\u2014Biological and translational implications","volume":"11","author":"Baylin","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s12276-026-01650-1","article-title":"Metabolic crosstalk among cancer-associated fibroblasts, adipocytes and immune cells as an immunosuppressive tumor microenvironment driver","volume":"58","author":"Kim","year":"2026","journal-title":"Exp. Mol. Med."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth","volume":"41","author":"Joyce","year":"2023","journal-title":"Cancer Cell"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1053\/j.gastro.2015.04.010","article-title":"Exclusion of T Cells From Pancreatic Carcinomas in Mice Is Regulated by Ly6C(low) F4\/80(+) Extratumoral Macrophages","volume":"149","author":"Beatty","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/cas.13944","article-title":"Distinct chemotherapy-associated anti-cancer immunity by myeloid cells inhibition in murine pancreatic cancer models","volume":"110","author":"Sakai","year":"2019","journal-title":"Cancer Sci."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ccr.2005.08.002","article-title":"Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors","volume":"8","author":"Venneri","year":"2005","journal-title":"Cancer Cell"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.it.2007.09.004","article-title":"Tie2-expressing monocytes: Regulation of tumor angiogenesis and therapeutic implications","volume":"28","author":"Murdoch","year":"2007","journal-title":"Trends Immunol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"5276","DOI":"10.1182\/blood-2006-10-053504","article-title":"Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer","volume":"109","author":"Venneri","year":"2007","journal-title":"Blood"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Hirayama, D., Iida, T., and Nakase, H. (2017). The Phagocytic Function of Macrophage-Enforcing Innate Immunity and Tissue Homeostasis. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19010092"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1080\/08830185.2020.1732958","article-title":"Phagocytosis: Phenotypically Simple Yet a Mechanistically Complex Process","volume":"39","author":"Kumar","year":"2020","journal-title":"Int. Rev. Immunol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1189\/jlb.0312166","article-title":"Plenary Perspective: The complexity of constitutive and inducible gene expression in mononuclear phagocytes","volume":"92","author":"Hume","year":"2012","journal-title":"J. Leukoc. Biol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.trecan.2015.11.004","article-title":"Ontogeny of Tumor-associated Macrophages and Its Implication in Cancer Regulation","volume":"2","author":"Franklin","year":"2016","journal-title":"Trends Cancer"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/236168a0","article-title":"Mechanism of Immunologically Specific Killing of Tumour Cells by Macrophages","volume":"236","author":"Evans","year":"1972","journal-title":"Nature"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1126\/science.145.3639.1427","article-title":"Homograft target cells: Specific destruction in vitro by contact interaction with immune macrophages","volume":"145","author":"Granger","year":"1964","journal-title":"Science"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1126\/science.151.3706.97","article-title":"Homograft target cells: Contact destruction in vitro by immune macrophages","volume":"151","author":"Granger","year":"1966","journal-title":"Science"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF00305967","article-title":"Phagocytosis of monocytes in cancer patients","volume":"91","author":"Kuntz","year":"1978","journal-title":"Z. Krebsforsch. Klin. Onkol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF00205307","article-title":"A quantitative and qualitative study of blood monocytes in patients with bronchogenic carcinoma","volume":"13","author":"Nielsen","year":"1982","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_123","first-page":"19","article-title":"Macrophages and the tumour bearing host","volume":"1","author":"Evans","year":"1973","journal-title":"Br. J. Cancer Suppl."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/jcp.36.3.316","article-title":"Disordered function of mononuclear phagocytes in malignant disease","volume":"36","author":"Sokol","year":"1983","journal-title":"J. Clin. Pathol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/jcp.s3-7.1.77","article-title":"The role of macrophages in tumour immunity","volume":"7","author":"Alexander","year":"1974","journal-title":"J. Clin. Pathol. Suppl. (R. Coll. Pathol.)"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"e70304","DOI":"10.1002\/mco2.70304","article-title":"Macrophages: Subtypes, Distribution, Polarization, Immunomodulatory Functions, and Therapeutics","volume":"6","author":"Peng","year":"2025","journal-title":"MedComm"},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Chang, Y., Lei, Y., Wang, L., Liu, L., and Yu, R. (2026). Decoding the dual roles of monocytes in tumor immunity: From immunosurveillance to immune evasion. Front. Immunol., 17.","DOI":"10.3389\/fimmu.2026.1805868"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1126\/science.2432665","article-title":"Macrophage cytotoxicity: Role for L-arginine deiminase and imino nitrogen oxidation to nitrite","volume":"235","author":"Hibbs","year":"1987","journal-title":"Science"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41577-025-01258-y","article-title":"Metabolites as signalling molecules in the tumour immune microenvironment","volume":"26","author":"Mao","year":"2026","journal-title":"Nat. Rev. Immunol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature12034","article-title":"Macrophage biology in development, homeostasis and disease","volume":"496","author":"Wynn","year":"2013","journal-title":"Nature"},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Cotechini, T., Atallah, A., and Grossman, A. (2021). Tissue-Resident and Recruited Macrophages in Primary Tumor and Metastatic Microenvironments: Potential Targets in Cancer Therapy. Cells, 10.","DOI":"10.3390\/cells10040960"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/s41590-022-01267-2","article-title":"The complex role of tumor-infiltrating macrophages","volume":"23","author":"Christofides","year":"2022","journal-title":"Nat. Immunol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"550","DOI":"10.4049\/jimmunol.138.2.550","article-title":"L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells","volume":"138","author":"Hibbs","year":"1987","journal-title":"J. Immunol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0006-291X(88)80015-9","article-title":"Nitric oxide: A cytotoxic activated macrophage effector molecule","volume":"157","author":"Hibbs","year":"1988","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.4049\/jimmunol.149.8.2709","article-title":"Macrophage arginine metabolism and the inhibition or stimulation of cancer","volume":"149","author":"Mills","year":"1992","journal-title":"J. Immunol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.4049\/jimmunol.146.8.2719","article-title":"Molecular basis of \u201csuppressor\u201d macrophages. Arginine metabolism via the nitric oxide synthetase pathway","volume":"146","author":"Mills","year":"1991","journal-title":"J. Immunol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1006\/cimm.1999.1597","article-title":"Macrophage-derived nitric oxide inhibits the proliferation of activated T helper cells and is induced during antigenic stimulation of resting T cells","volume":"199","author":"Dietlin","year":"2000","journal-title":"Cell. Immunol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"e1204506","DOI":"10.1080\/2162402X.2016.1204506","article-title":"Macrophage-derived nitric oxide initiates T-cell diapedesis and tumor rejection","volume":"5","author":"Sektioglu","year":"2016","journal-title":"Oncoimmunology"},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Fauskanger, M., Haabeth, O.A.W., Skjeldal, F.M., Bogen, B., and Tveita, A.A. (2018). Tumor Killing by CD4+ T Cells Is Mediated via Induction of Inducible Nitric Oxide Synthase-Dependent Macrophage Cytotoxicity. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.01684"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"dmm033332","DOI":"10.1242\/dmm.033332","article-title":"Arginine and the metabolic regulation of nitric oxide synthesis in cancer","volume":"11","author":"Keshet","year":"2018","journal-title":"Dis. Models Mech."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"46222","DOI":"10.31083\/FBL46222","article-title":"Dual Role of Nitric Oxide in Tumor Immunity and Its Therapeutic Application","volume":"31","author":"Kang","year":"2026","journal-title":"Front. Biosci. (Landmark Ed.)"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"50731","DOI":"10.18632\/oncotarget.14913","article-title":"Macrophages promote the progression of premalignant mammary lesions to invasive cancer","volume":"8","author":"Carron","year":"2017","journal-title":"Oncotarget"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41586-021-03651-8","article-title":"Tissue-resident macrophages provide a pro-tumorigenic niche to early NSCLC cells","volume":"595","author":"Dalla","year":"2021","journal-title":"Nature"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/ni.1781","article-title":"Foamy macrophages and the progression of the human tuberculosis granuloma","volume":"10","author":"Russell","year":"2009","journal-title":"Nat. Immunol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/nprot.2009.95","article-title":"Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase","volume":"4","author":"DuPage","year":"2009","journal-title":"Nat. Protoc."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1073\/pnas.1319963111","article-title":"Multiple cells-of-origin of mutant K-Ras-induced mouse lung adenocarcinoma","volume":"111","author":"Sutherland","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1038\/s41467-024-48700-8","article-title":"Single-cell and spatial transcriptomics analysis of non-small cell lung cancer","volume":"15","author":"Xue","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Haug, M., Pettersen, H.S., B\u00f8rset, M., Kildahl-Andersen, A., Wahl, S.G.F., Flatberg, A., and T\u00f8ndell, A. (2026). Immune-cold NSCLC tumors harbor tumor-associated macrophages with elevated expression of immunoglobulin genes. Cancer Immunol. Immunother.","DOI":"10.1007\/s00262-026-04446-4"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.21037\/tlcr-2025-912","article-title":"Single-cell and spatial analysis reveals macrophage-T cell crosstalk in non-small cell lung cancer immunosuppression","volume":"14","author":"Zhu","year":"2025","journal-title":"Transl. Lung Cancer Res."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"907092","DOI":"10.1155\/2010\/907092","article-title":"The emerging role of HLA-E-restricted CD8+ T lymphocytes in the adaptive immune response to pathogens and tumors","volume":"2010","author":"Pietra","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.2174\/138161209789105207","article-title":"HLA-E and HLA-E-bound peptides: Recognition by subsets of NK and T cells","volume":"15","author":"Pietra","year":"2009","journal-title":"Curr. Pharm. Des."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/35869","article-title":"HLA-E binds to natural killer cell receptors CD94\/NKG2A, B and C","volume":"391","author":"Braud","year":"1998","journal-title":"Nature"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"e000778","DOI":"10.1136\/jitc-2020-000778","article-title":"M1(hot) tumor-associated macrophages boost tissue-resident memory T cells infiltration and survival in human lung cancer","volume":"8","author":"Mellows","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.cell.2017.04.014","article-title":"Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses","volume":"169","author":"Lavin","year":"2017","journal-title":"Cell"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"e45858","DOI":"10.1097\/MD.0000000000045858","article-title":"LC3 overexpression in colorectal cancer\u2014Strong correlation with M1 tumor-associated macrophages: An observational study","volume":"104","author":"Xu","year":"2025","journal-title":"Medicine"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-1-59745-157-4_4","article-title":"LC3 and Autophagy","volume":"445","author":"Tanida","year":"2008","journal-title":"Methods Mol. Biol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"101170","DOI":"10.1016\/j.drup.2024.101170","article-title":"Autophagy in cancer development, immune evasion, and drug resistance","volume":"78","author":"Niu","year":"2025","journal-title":"Drug Resist. Updates"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41568-021-00344-2","article-title":"Autophagy in tumour immunity and therapy","volume":"21","author":"Xia","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/imr.12211","article-title":"Transcriptomic analysis of mononuclear phagocyte differentiation and activation","volume":"262","author":"Hume","year":"2014","journal-title":"Immunol. Rev."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines","volume":"41","author":"Murray","year":"2014","journal-title":"Immunity"},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Gordon, S., and Pl\u00fcddemann, A. (2017). Tissue macrophages: Heterogeneity and functions. BMC Biol., 15.","DOI":"10.1186\/s12915-017-0392-4"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/imr.12223","article-title":"Macrophage heterogeneity in tissues: Phenotypic diversity and functions","volume":"262","author":"Gordon","year":"2014","journal-title":"Immunol. Rev."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1002\/1878-0261.13618","article-title":"From monocyte-derived macrophages to resident macrophages-how metabolism leads their way in cancer","volume":"18","author":"Ammarah","year":"2024","journal-title":"Mol. Oncol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41590-023-01688-7","article-title":"Human serous cavity macrophages and dendritic cells possess counterparts in the mouse with a distinct distribution between species","volume":"25","author":"Han","year":"2024","journal-title":"Nat. Immunol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nrd.2018.169","article-title":"Targeting macrophages: Therapeutic approaches in cancer","volume":"17","author":"Cassetta","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bbcan.2015.06.009","article-title":"Tissue-resident versus monocyte-derived macrophages in the tumor microenvironment","volume":"1865","author":"Lahmar","year":"2016","journal-title":"Biochim. Biophys. Acta (BBA)-Rev. Cancer"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","article-title":"Macrophages as tools and targets in cancer therapy","volume":"21","author":"Mantovani","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","article-title":"Tumour-associated macrophages as treatment targets in oncology","volume":"14","author":"Mantovani","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Doig, T.N., Hume, D.A., Theocharidis, T., Goodlad, J.R., Gregory, C.D., and Freeman, T.C. (2013). Coexpression analysis of large cancer datasets provides insight into the cellular phenotypes of the tumour microenvironment. BMC Genom., 14.","DOI":"10.1186\/1471-2164-14-469"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"5054","DOI":"10.1182\/blood-2007-12-130609","article-title":"Epigenetic control of MHC class II expression in tumor-associated macrophages by decoy receptor 3","volume":"111","author":"Chang","year":"2008","journal-title":"Blood"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"117230","DOI":"10.1016\/j.celrep.2026.117230","article-title":"Pan-cancer macrophage atlas uncovers that MHC-IIhigh TAMs induce Treg activation through physical interactions","volume":"45","author":"Yang","year":"2026","journal-title":"Cell Rep."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"115574","DOI":"10.1016\/j.celrep.2025.115574","article-title":"MHC class II+ macrophage differentiation is impaired in metastasized lungs via PGE2 receptor EP2","volume":"44","author":"Jeong","year":"2025","journal-title":"Cell Rep."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"eadn8608","DOI":"10.1126\/science.adn8608","article-title":"Platelet factor 4\u2013induced TH1-Treg polarization suppresses antitumor immunity","volume":"386","author":"Kuratani","year":"2024","journal-title":"Science"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.immuni.2023.06.003","article-title":"CXCR3 expression in regulatory T cells drives interactions with type I dendritic cells in tumors to restrict CD8(+) T cell antitumor immunity","volume":"56","author":"Campbell","year":"2023","journal-title":"Immunity"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41388-020-01528-0","article-title":"Single-cell RNA sequencing reveals heterogeneous tumor and immune cell populations in early-stage lung adenocarcinomas harboring EGFR mutations","volume":"40","author":"He","year":"2021","journal-title":"Oncogene"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"6748","DOI":"10.1038\/s41388-021-02054-3","article-title":"Single-cell RNA sequencing reveals distinct tumor microenvironmental patterns in lung adenocarcinoma","volume":"40","author":"Bischoff","year":"2021","journal-title":"Oncogene"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"e70090","DOI":"10.1002\/eji.70090","article-title":"The Phenotypical and Functional Effect of PGE2 on Human Macrophages","volume":"55","author":"Pfirrmann","year":"2025","journal-title":"Eur. J. Immunol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"565","DOI":"10.4049\/jimmunol.1202462","article-title":"PGE(2) induces macrophage IL-10 production and a regulatory-like phenotype via a protein kinase A-SIK-CRTC3 pathway","volume":"190","author":"MacKenzie","year":"2013","journal-title":"J. Immunol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"15642","DOI":"10.1073\/pnas.1519644112","article-title":"CREB pathway links PGE2 signaling with macrophage polarization","volume":"112","author":"Luan","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1158\/0008-5472.CAN-25-0079","article-title":"Tumor-Associated Macrophages Produce PGE2 to Promote CD8+ T-cell Exhaustion and Drive Resistance to PD-L1 Blockade in Microsatellite-Stable Colorectal Cancer","volume":"86","author":"Fumet","year":"2026","journal-title":"Cancer Res."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/s41586-019-0924-x","article-title":"Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution","volume":"566","author":"Masuda","year":"2019","journal-title":"Nature"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"6936","DOI":"10.1073\/pnas.95.12.6936","article-title":"Differential expression of major histocompatibility complex class II genes on murine macrophages associated with T cell cytokine profile and protective\/suppressive effects","volume":"95","author":"Baumgart","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1038\/s41598-023-28554-8","article-title":"MHCII expression on gut macrophages supports T cell homeostasis and is regulated by microbiota and ontogeny","volume":"13","author":"Guillaume","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/s41590-023-01475-4","article-title":"TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer","volume":"24","author":"Park","year":"2023","journal-title":"Nat. Immunol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"101739","DOI":"10.1016\/j.smim.2023.101739","article-title":"TREM2: A new player in the tumor microenvironment","volume":"67","author":"Molgora","year":"2023","journal-title":"Semin. Immunol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bbrc.2022.10.079","article-title":"TREM2 knockdown improves the therapeutic effect of PD-1 blockade in hepatocellular carcinoma","volume":"636","author":"Wang","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"eade3559","DOI":"10.1126\/sciadv.ade3559","article-title":"TREM2 inhibition triggers antitumor cell activity of myeloid cells in glioblastoma","volume":"9","author":"Sun","year":"2023","journal-title":"Sci. Adv."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/neuonc\/noad257","article-title":"Triggering receptor expressed on myeloid cells 2 (TREM2) regulates phagocytosis in glioblastoma","volume":"26","author":"Peshoff","year":"2024","journal-title":"Neuro Oncol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1016\/j.immuni.2024.09.007","article-title":"Microglia and monocyte-derived macrophages drive progression of pediatric high-grade gliomas and are transcriptionally shaped by histone mutations","volume":"57","author":"Ross","year":"2024","journal-title":"Immunity"},{"key":"ref_190","doi-asserted-by":"crossref","unstructured":"Zhang, C.R., Xiong, L., Gu, M., Yeh, C.Y., Jerby, L., Kundaje, A., Greenleaf, W.J., and Bassik, M.C. (2025). Cancer cell phagocytosis induces an anti-inflammatory gene regulatory program in macrophages. bioRxiv.","DOI":"10.1101\/2025.08.18.670953"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/s41591-025-04177-6","article-title":"Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockade","volume":"32","author":"Sweeney","year":"2026","journal-title":"Nat. Med."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/s43018-024-00731-2","article-title":"Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis","volume":"5","author":"Astuti","year":"2024","journal-title":"Nat. Cancer"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/ncb3340","article-title":"Macrophage-secreted granulin supports pancreatic cancer metastasis by inducing liver fibrosis","volume":"18","author":"Nielsen","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1038\/s41467-024-47949-3","article-title":"Macrophage-fibroblast JAK\/STAT dependent crosstalk promotes liver metastatic outgrowth in pancreatic cancer","volume":"15","author":"Raymant","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"6043","DOI":"10.1038\/s41467-024-50450-6","article-title":"Necroptosis enhances \u2018don\u2019t eat me\u2019 signal and induces macrophage extracellular traps to promote pancreatic cancer liver metastasis","volume":"15","author":"Liao","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.1252510","article-title":"The cellular and molecular origin of tumor-associated macrophages","volume":"344","author":"Franklin","year":"2014","journal-title":"Science"},{"key":"ref_197","first-page":"133","article-title":"The role of tumor-associated macrophage in breast cancer biology","volume":"33","author":"Choi","year":"2018","journal-title":"Histol. Histopathol."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s00018-025-05908-1","article-title":"The transcription factor RBPJ is required for inflammatory macrophage activation in thoracic aortic dissection by mediating mechanotransduction-induced glycolysis","volume":"82","author":"Yin","year":"2025","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"4840","DOI":"10.1158\/0008-5472.CAN-10-0269","article-title":"Notch signaling determines the M1 versus M2 polarization of macrophages in antitumor immune responses","volume":"70","author":"Wang","year":"2010","journal-title":"Cancer Res."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s13238-016-0248-7","article-title":"RBP-J is required for M2 macrophage polarization in response to chitin and mediates expression of a subset of M2 genes","volume":"7","author":"Foldi","year":"2016","journal-title":"Protein Cell"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/ni932","article-title":"SOCS3 regulates the plasticity of gp130 signaling","volume":"4","author":"Lang","year":"2003","journal-title":"Nat. Immunol."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.4049\/jimmunol.1201168","article-title":"SOCS3 deficiency promotes M1 macrophage polarization and inflammation","volume":"189","author":"Qin","year":"2012","journal-title":"J. Immunol."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.1158\/0008-5472.CAN-10-0012","article-title":"Angiopoietin-2 regulates gene expression in TIE2-expressing monocytes and augments their inherent proangiogenic functions","volume":"70","author":"Coffelt","year":"2010","journal-title":"Cancer Res."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"e180893","DOI":"10.1172\/JCI180893","article-title":"Tumor-initiating cells escape tumor immunity via CCL8 from tumor-associated macrophages in mice","volume":"135","author":"Chen","year":"2025","journal-title":"J. Clin. Investig."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"111951","DOI":"10.1016\/j.cellsig.2025.111951","article-title":"Insights on the role of the chemokine CCL8 in pathology","volume":"134","author":"Chavez","year":"2025","journal-title":"Cell. Signal."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/s41374-019-0345-3","article-title":"CCL8 secreted by tumor-associated macrophages promotes invasion and stemness of glioblastoma cells via ERK1\/2 signaling","volume":"100","author":"Zhang","year":"2020","journal-title":"Lab. Investig."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.immuni.2024.11.026","article-title":"Antigen presentation by tumor-associated macrophages drives T cells from a progenitor exhaustion state to terminal exhaustion","volume":"58","author":"Tomaszewski","year":"2025","journal-title":"Immunity"},{"key":"ref_208","first-page":"eadw8291","article-title":"Macrophages restrict tumor immune infiltration by controlling collagen topography","volume":"11","author":"Fusilier","year":"2026","journal-title":"Sci. Immunol."},{"key":"ref_209","doi-asserted-by":"crossref","unstructured":"Belgiovine, C., Digifico, E., Anfray, C., Ummarino, A., and Torres And\u00f3n, F. (2020). Targeting Tumor-Associated Macrophages in Anti-Cancer Therapies: Convincing the Traitors to Do the Right Thing. J. Clin. Med., 9.","DOI":"10.3390\/jcm9103226"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/s41423-024-01232-z","article-title":"Targeting of TAMs: Can we be more clever than cancer cells?","volume":"21","author":"Kzhyshkowska","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/s41416-024-02715-6","article-title":"Clinical landscape of macrophage-reprogramming cancer immunotherapies","volume":"131","author":"Rannikko","year":"2024","journal-title":"Br. J. Cancer"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ccell.2026.01.020","article-title":"Macrophages: Targets for next-generation cancer immunotherapy","volume":"44","author":"Sun","year":"2026","journal-title":"Cancer Cell"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/s41568-022-00547-1","article-title":"A timeline of tumour-associated macrophage biology","volume":"23","author":"Cassetta","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41571-022-00620-6","article-title":"Clinical relevance of tumour-associated macrophages","volume":"19","author":"Pittet","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ccell.2015.02.015","article-title":"Macrophages and therapeutic resistance in cancer","volume":"27","author":"Ruffell","year":"2015","journal-title":"Cancer Cell"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","article-title":"Tumor-associated macrophages: From mechanisms to therapy","volume":"41","author":"Noy","year":"2014","journal-title":"Immunity"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.cell.2023.02.020","article-title":"Macrophages at the interface of the co-evolving cancer ecosystem","volume":"186","author":"Kloosterman","year":"2023","journal-title":"Cell"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.it.2023.10.007","article-title":"Tumor macrophage functional heterogeneity can inform the development of novel cancer therapies","volume":"44","author":"Nasir","year":"2023","journal-title":"Trends Immunol."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/s41587-020-0462-y","article-title":"Human chimeric antigen receptor macrophages for cancer immunotherapy","volume":"38","author":"Klichinsky","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrd.2017.84","article-title":"CAR T therapies drive into new terrain","volume":"16","author":"Kingwell","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMoa1709866","article-title":"Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia","volume":"378","author":"Maude","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa1708566","article-title":"Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas","volume":"377","author":"Schuster","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.apsb.2020.10.020","article-title":"CAR-T cells: Early successes in blood cancer and challenges in solid tumors","volume":"11","author":"Dana","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/s41419-024-07267-4","article-title":"Inhibition of furin in CAR macrophages directs them toward a proinflammatory phenotype and enhances their antitumor activities","volume":"15","author":"Hajjaji","year":"2024","journal-title":"Cell Death Dis."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41698-025-01170-7","article-title":"CAR-macrophages in solid tumors: Promise, progress, and prospects","volume":"9","author":"Alrehaili","year":"2025","journal-title":"npj Precis. Oncol."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41590-023-01687-8","article-title":"A second-generation M1-polarized CAR macrophage with antitumor efficacy","volume":"25","author":"Lei","year":"2024","journal-title":"Nat. Immunol."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"8175","DOI":"10.1038\/s41598-026-39406-6","article-title":"Optimization of THP-1-CAR monocytes utilizing CD32a signaling phagocytosis for antigen-specific T cell activation","volume":"16","author":"Hong","year":"2026","journal-title":"Sci. Rep."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/s41591-025-03495-z","article-title":"CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: A phase 1 trial","volume":"31","author":"Reiss","year":"2025","journal-title":"Nat. Med."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.stem.2024.03.018","article-title":"Human anti-PSCA CAR macrophages possess potent antitumor activity against pancreatic cancer","volume":"31","author":"Shah","year":"2024","journal-title":"Cell Stem Cell"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"e2103258","DOI":"10.1002\/adma.202103258","article-title":"Nanocomplex-Mediated In Vivo Programming to Chimeric Antigen Receptor-M1 Macrophages for Cancer Therapy","volume":"33","author":"Kang","year":"2021","journal-title":"Adv. Mater."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.stem.2024.05.006","article-title":"CAR macrophages tuning the immune symphony of anti-cancer therapies","volume":"31","author":"Paasch","year":"2024","journal-title":"Cell Stem Cell"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13046-022-02327-z","article-title":"CAR race to cancer immunotherapy: From CAR T, CAR NK to CAR macrophage therapy","volume":"41","author":"Pan","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s40364-024-00637-2","article-title":"CAR Macrophages: A promising novel immunotherapy for solid tumors and beyond","volume":"12","author":"Lu","year":"2024","journal-title":"Biomark. Res."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1038\/s41467-025-59326-9","article-title":"CAR macrophages with built-In CD47 blocker combat tumor antigen heterogeneity and activate T cells via cross-presentation","volume":"16","author":"Chen","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/s41423-024-01220-3","article-title":"Silencing of SIRP\u03b1 enhances the antitumor efficacy of CAR-M in solid tumors","volume":"21","author":"Zhang","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/s43018-023-00691-z","article-title":"Sirp\u03b1 on tumor-associated myeloid cells restrains antitumor immunity in colorectal cancer independent of its interaction with CD47","volume":"5","author":"Huang","year":"2024","journal-title":"Nat. Cancer"},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41586-024-07443-8","article-title":"Engineered CD47 protects T cells for enhanced antitumour immunity","volume":"630","author":"Theruvath","year":"2024","journal-title":"Nature"},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1038\/s41467-026-70221-9","article-title":"Dual phagocytosis-checkpoint blockade revitalizes immune surveillance in mouse models of glioblastoma","volume":"17","author":"Ha","year":"2026","journal-title":"Nat. Commun."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1126\/science.153.3739.1004","article-title":"Immunization of normal mouse spleen cell suspensions in vitro","volume":"153","author":"Mishell","year":"1966","journal-title":"Science"},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1126\/science.158.3808.1573","article-title":"A requirement for two cell types for antibody formation in vitro","volume":"158","author":"Mosier","year":"1967","journal-title":"Science"},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1084\/jem.137.5.1142","article-title":"Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution","volume":"137","author":"Steinman","year":"1973","journal-title":"J. Exp. Med."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1084\/jem.139.2.380","article-title":"Identification of a novel cell type in peripheral lymphoid organs of mice. II. Functional properties in vitro","volume":"139","author":"Steinman","year":"1974","journal-title":"J. Exp. Med."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.149.1.1","article-title":"Identification of a novel cell type in peripheral lymphoid organs of mice. V. Purification of spleen dendritic cells, new surface markers, and maintenance in vitro","volume":"149","author":"Steinman","year":"1979","journal-title":"J. Exp. Med."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1073\/pnas.75.10.5132","article-title":"Lymphoid dendritic cells are potent stimulators of the primary mixed leukocyte reaction in mice","volume":"75","author":"Steinman","year":"1978","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1084\/jem.151.5.1196","article-title":"Contribution of dendritic cells to stimulation of the murine syngeneic mixed leukocyte reaction","volume":"151","author":"Nussenzweig","year":"1980","journal-title":"J. Exp. Med."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1084\/jem.2037fta","article-title":"Kicking off adaptive immunity: The discovery of dendritic cells","volume":"203","author":"Katsnelson","year":"2006","journal-title":"J. Exp. Med."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1084\/jem.152.4.1070","article-title":"Dendritic cells are accessory cells for the development of anti-trinitrophenyl cytotoxic T lymphocytes","volume":"152","author":"Nussenzweig","year":"1980","journal-title":"J. Exp. Med."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.1073\/pnas.80.19.6041","article-title":"Dendritic cells are critical accessory cells for thymus-dependent antibody responses in mouse and in man","volume":"80","author":"Inaba","year":"1983","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1084\/jem.161.3.526","article-title":"Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro","volume":"161","author":"Schuler","year":"1985","journal-title":"J. Exp. Med."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1084\/jem.169.3.1169","article-title":"Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells","volume":"169","author":"Romani","year":"1989","journal-title":"J. Exp. Med."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1084\/jem.158.1.174","article-title":"Relative efficacy of human monocytes and dendritic cells as accessory cells for T cell replication","volume":"158","author":"Valinsky","year":"1983","journal-title":"J. Exp. Med."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.156.1.1","article-title":"Accessory and stimulating properties of dendritic cells and macrophages isolated from various rat tissues","volume":"156","author":"Klinkert","year":"1982","journal-title":"J. Exp. Med."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41577-018-0088-1","article-title":"Dendritic cell subsets in T cell programming: Location dictates function","volume":"19","author":"Eisenbarth","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"ref_254","first-page":"35","article-title":"Immunotherapy of cancer using dendritic cells","volume":"4","author":"Morse","year":"1998","journal-title":"Cytokines Cell Mol. Ther."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0165-2478(00)00254-6","article-title":"Development of dendritic-cell based prostate cancer vaccine","volume":"74","author":"Tjoa","year":"2000","journal-title":"Immunol. Lett."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2174\/1566523023348129","article-title":"Cancer immunotherapy using gene-modified dendritic cells","volume":"2","author":"Ribas","year":"2002","journal-title":"Curr. Gene Ther."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/00002371-200309000-00006","article-title":"Single Injection of CD34+ Progenitor-Derived Dendritic Cell Vaccine Can Lead to Induction of T-Cell Immunity in Patients with Stage IV Melanoma","volume":"26","author":"Palucka","year":"2003","journal-title":"J. Immunother."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nm0398-328","article-title":"Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells","volume":"4","author":"Nestle","year":"1998","journal-title":"Nat. Med."},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1084\/jem.190.11.1669","article-title":"Vaccination with Mage-3a1 Peptide\u2013Pulsed Mature, Monocyte-Derived Dendritic Cells Expands Specific Cytotoxic T Cells and Induces Regression of Some Metastases in Advanced Stage IV Melanoma","volume":"190","author":"Thurner","year":"1999","journal-title":"J. Exp. Med."},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/ni.2160","article-title":"Ralph Steinman 1943\u20132011","volume":"12","author":"Nathan","year":"2011","journal-title":"Nat. Immunol."},{"key":"ref_261","doi-asserted-by":"crossref","unstructured":"Wang, R., Chen, Y., and Fang, Y.-f. (2026). Dendritic cell diversity and dysfunction in cancer: Implications for immunotherapy and therapeutic targeting. Acta Pharmacol. Sin.","DOI":"10.1038\/s41401-026-01868-9"},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41568-024-00787-3","article-title":"Dendritic cell maturation in cancer","volume":"25","author":"Moon","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41577-024-01026-4","article-title":"Cancer cell metabolism and antitumour immunity","volume":"24","author":"Rathmell","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.ccell.2024.05.025","article-title":"Intratumoral immune triads are required for immunotherapy-mediated elimination of solid tumors","volume":"42","author":"Chiu","year":"2024","journal-title":"Cancer Cell"},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.immuni.2018.09.024","article-title":"Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-\u03b3 and IL-12","volume":"49","author":"Garris","year":"2018","journal-title":"Immunity"},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"111201","DOI":"10.1016\/j.celrep.2022.111201","article-title":"Stromal remodeling regulates dendritic cell abundance and activity in the tumor microenvironment","volume":"40","author":"Papadas","year":"2022","journal-title":"Cell Rep."},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41590-025-02354-w","article-title":"Cross-presentation of dead cell-associated antigens shapes the neoantigenic landscape of tumor immunity","volume":"27","author":"Lim","year":"2026","journal-title":"Nat. Immunol."},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41586-023-06299-8","article-title":"SLC38A2 and glutamine signalling in cDC1s dictate anti-tumour immunity","volume":"620","author":"Guo","year":"2023","journal-title":"Nature"},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/ni.3196","article-title":"The transcription factor TFEB acts as a molecular switch that regulates exogenous antigen-presentation pathways","volume":"16","author":"Samie","year":"2015","journal-title":"Nat. Immunol."},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41467-022-35615-5","article-title":"CD4+ helper T cells endow cDC1 with cancer-impeding functions in the human tumor micro-environment","volume":"14","author":"Lei","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41423-024-01133-1","article-title":"CD4+ T cells produce IFN-I to license cDC1s for induction of cytotoxic T-cell activity in human tumors","volume":"21","author":"Lei","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41586-020-2611-3","article-title":"cDC1 prime and are licensed by CD4(+) T cells to induce anti-tumour immunity","volume":"584","author":"Ferris","year":"2020","journal-title":"Nature"},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1038\/s41590-022-01324-w","article-title":"Mechanisms of CD40-dependent cDC1 licensing beyond costimulation","volume":"23","author":"Wu","year":"2022","journal-title":"Nat. Immunol."},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/s41586-023-06199-x","article-title":"CD4+ T cell-induced inflammatory cell death controls immune-evasive tumours","volume":"618","author":"Kruse","year":"2023","journal-title":"Nature"},{"key":"ref_275","doi-asserted-by":"crossref","unstructured":"Peterson, E.E., and Barry, K.C. (2020). The Natural Killer-Dendritic Cell Immune Axis in Anti-Cancer Immunity and Immunotherapy. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.621254"},{"key":"ref_276","doi-asserted-by":"crossref","unstructured":"B\u00f6dder, J., Zahan, T., van Slooten, R., Schreibelt, G., de Vries, I.J.M., and Fl\u00f3rez-Grau, G. (2020). Harnessing the cDC1-NK Cross-Talk in the Tumor Microenvironment to Battle Cancer. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.631713"},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1016\/j.immuni.2023.08.014","article-title":"Dendritic cells as shepherds of T cell immunity in cancer","volume":"56","author":"Pittet","year":"2023","journal-title":"Immunity"},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s41591-018-0085-8","article-title":"A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments","volume":"24","author":"Barry","year":"2018","journal-title":"Nat. Med."},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1016\/j.cell.2024.04.009","article-title":"FLT3L governs the development of partially overlapping hematopoietic lineages in humans and mice","volume":"187","author":"Momenilandi","year":"2024","journal-title":"Cell"},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.cell.2018.01.004","article-title":"NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control","volume":"172","author":"Bonavita","year":"2018","journal-title":"Cell"},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.immuni.2023.05.011","article-title":"Tumor-derived prostaglandin E2 programs cDC1 dysfunction to impair intratumoral orchestration of anti-cancer T cell responses","volume":"56","author":"Bayerl","year":"2023","journal-title":"Immunity"},{"key":"ref_282","doi-asserted-by":"crossref","unstructured":"Hato, L., Vizcay, A., Eguren, I., P\u00e9rez-Gracia, J.L., Rodr\u00edguez, J., G\u00e1llego P\u00e9rez-Larraya, J., Sarobe, P., Inog\u00e9s, S., D\u00edaz de Cerio, A.L., and Santisteban, M. (2024). Dendritic Cells in Cancer Immunology and Immunotherapy. Cancers, 16.","DOI":"10.3390\/cancers16050981"},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/17588359211064653","article-title":"Final results regarding the addition of dendritic cell vaccines to neoadjuvant chemotherapy in early HER2-negative breast cancer patients: Clinical and translational analysis","volume":"13","author":"Santisteban","year":"2021","journal-title":"Ther. Adv. Med. Oncol."},{"key":"ref_284","doi-asserted-by":"crossref","unstructured":"Mej\u00edas Sosa, L., L\u00f3pez-Janeiro, \u00c1., C\u00f3rdoba Iturriagagoitia, A., Sala, P., Solans, B.P., Hato, L., Inog\u00e9s, S., L\u00f3pez-D\u00edaz de Cerio, A., Guill\u00e9n-Grima, F., and Espin\u00f3s, J. (2023). Modification of Breast Cancer Milieu with Chemotherapy plus Dendritic Cell Vaccine: An Approach to Select Best Therapeutic Strategies. Biomedicines, 11.","DOI":"10.3390\/biomedicines11020238"},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1001294","article-title":"Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer","volume":"363","author":"Berger","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_286","first-page":"197","article-title":"Sipuleucel-T (provenge) injection: The first immunotherapy agent (vaccine) for hormone-refractory prostate cancer","volume":"36","author":"Anassi","year":"2011","journal-title":"Pharm. Ther."},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1586\/14760584.2015.1099437","article-title":"Prostate Cancer Immunotherapy with Sipuleucel-T: Current Standards and Future Directions","volume":"14","author":"Wei","year":"2015","journal-title":"Expert Rev. Vaccines"},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41423-021-00741-5","article-title":"Dendritic cells in cancer immunology","volume":"19","author":"Murphy","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41571-024-00859-1","article-title":"Dendritic cells as orchestrators of anticancer immunity and immunotherapy","volume":"21","author":"Wculek","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.semcancer.2003.09.008","article-title":"Dendritic cells as vectors for immunotherapy of cancer","volume":"13","author":"Paczesny","year":"2003","journal-title":"Semin. Cancer Biol."},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0952-7915(00)00146-1","article-title":"The dendritic cell and human cancer vaccines","volume":"12","author":"Dallal","year":"2000","journal-title":"Curr. Opin. Immunol."},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.it.2016.09.006","article-title":"Dendritic Cells and Cancer Immunity","volume":"37","author":"Gardner","year":"2016","journal-title":"Trends Immunol."},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"eabm9409","DOI":"10.1126\/sciimmunol.abm9409","article-title":"Human dendritic cells in cancer","volume":"7","author":"Kvedaraite","year":"2022","journal-title":"Sci. Immunol."},{"key":"ref_294","doi-asserted-by":"crossref","unstructured":"Matsuo, K., Yoshie, O., Kitahata, K., Kamei, M., Hara, Y., and Nakayama, T. (2021). Recent Progress in Dendritic Cell-Based Cancer Immunotherapy. Cancers, 13.","DOI":"10.3390\/cancers13102495"},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","article-title":"Dendritic cells in cancer immunology and immunotherapy","volume":"20","author":"Wculek","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref_296","doi-asserted-by":"crossref","unstructured":"Abascal, J., Oh, M.S., Liclican, E.L., Dubinett, S.M., Salehi-Rad, R., and Liu, B. (2023). Dendritic Cell Vaccination in Non-Small Cell Lung Cancer: Remodeling the Tumor Immune Microenvironment. Cells, 12.","DOI":"10.3390\/cells12192404"},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/s41419-025-08180-0","article-title":"The emerging role of dendritic cells in the tumor microenvironment: From antigen presentation to targeted immunotherapy","volume":"16","author":"Xie","year":"2025","journal-title":"Cell Death Dis."},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"117858","DOI":"10.1016\/j.biopha.2025.117858","article-title":"Revolutionizing cancer treatment: The power of dendritic cell-based vaccines in immunotherapy","volume":"184","author":"Sheykhhasan","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.ccell.2026.04.005","article-title":"Dendritic cell redundancy enables priming of anti-tumor CD4(+) T cells in pancreatic cancer","volume":"44","author":"Kureshi","year":"2026","journal-title":"Cancer Cell"},{"key":"ref_300","first-page":"294","article-title":"How Grim is Pancreatic Cancer?","volume":"10","author":"Weledji","year":"2016","journal-title":"Oncol. Rev."},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"eadn9083","DOI":"10.1126\/science.adn9083","article-title":"In vivo dendritic cell reprogramming for cancer immunotherapy","volume":"386","author":"Ascic","year":"2024","journal-title":"Science"},{"key":"ref_302","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.it.2020.11.001","article-title":"Tolerogenic Dendritic Cells in Autoimmunity and Inflammatory Diseases","volume":"42","author":"Fondelli","year":"2021","journal-title":"Trends Immunol."},{"key":"ref_303","doi-asserted-by":"crossref","unstructured":"Domogalla, M.P., Rostan, P.V., Raker, V.K., and Steinbrink, K. (2017). Tolerance through Education: How Tolerogenic Dendritic Cells Shape Immunity. Front. Immunol., 8.","DOI":"10.3389\/fimmu.2017.01764"},{"key":"ref_304","doi-asserted-by":"crossref","first-page":"eadi4191","DOI":"10.1126\/sciimmunol.adi4191","article-title":"A lactate-SREBP2 signaling axis drives tolerogenic dendritic cell maturation and promotes cancer progression","volume":"9","author":"Plebanek","year":"2024","journal-title":"Sci. Immunol."},{"key":"ref_305","doi-asserted-by":"crossref","unstructured":"Wang, X., Plebanek, M.P., Nguyen, Y.-V., Bazaz, M.R., Sturdivant, M., Theivanthiran, B., and Hanks, B.A. (2026). Tumor-derived Extracellular Vesicles Induce ER Stress to Drive Tolerogenic Dendritic Cell Development in the Tumor Microenvironment. bioRxiv.","DOI":"10.64898\/2026.02.10.705213"},{"key":"ref_306","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.immuni.2017.12.004","article-title":"Paracrine Wnt5a-\u03b2-Catenin Signaling Triggers a Metabolic Program that Drives Dendritic Cell Tolerization","volume":"48","author":"Zhao","year":"2018","journal-title":"Immunity"},{"key":"ref_307","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.tips.2023.04.006","article-title":"Modulation of T cells by tryptophan metabolites in the kynurenine pathway","volume":"44","author":"Stone","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_308","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1158\/0008-5472.CAN-08-2826","article-title":"Tumor-infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-arginine metabolism","volume":"69","author":"Norian","year":"2009","journal-title":"Cancer Res."},{"key":"ref_309","first-page":"2123","article-title":"CD3 zeta expression of regional lymph node and peripheral blood lymphocytes in gastric cancer","volume":"24","author":"Ishigami","year":"2004","journal-title":"Anticancer Res."},{"key":"ref_310","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cellimm.2005.01.004","article-title":"L-Arginine modulates CD3zeta expression and T cell function in activated human T lymphocytes","volume":"232","author":"Zea","year":"2004","journal-title":"Cell. Immunol."},{"key":"ref_311","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1158\/0008-5472.CAN-16-2212","article-title":"An Immunosuppressive Dendritic Cell Subset Accumulates at Secondary Sites and Promotes Metastasis in Pancreatic Cancer","volume":"77","author":"Kenkel","year":"2017","journal-title":"Cancer Res."},{"key":"ref_312","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1084\/jem.20050463","article-title":"Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation","volume":"202","author":"Ghiringhelli","year":"2005","journal-title":"J. Exp. Med."},{"key":"ref_313","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nri1498","article-title":"Mechanisms and functional significance of tumour-induced dendritic-cell defects","volume":"4","author":"Gabrilovich","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"ref_314","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1182\/blood-2011-05-357111","article-title":"IL-12 selectively programs effector pathways that are stably expressed in human CD8+ effector memory T cells in vivo","volume":"118","author":"Chowdhury","year":"2011","journal-title":"Blood"},{"key":"ref_315","doi-asserted-by":"crossref","first-page":"5516","DOI":"10.1182\/blood-2008-11-188458","article-title":"Reciprocal responsiveness to interleukin-12 and interferon-\u03b1 specifies human CD8+ effector versus central memory T-cell fates","volume":"113","author":"Ramos","year":"2009","journal-title":"Blood"},{"key":"ref_316","doi-asserted-by":"crossref","unstructured":"Yadav, M.K., Singh, S.P., and Egwuagu, C.E. (2025). IL-6\/IL-12 superfamily of cytokines and regulatory lymphocytes play critical roles in the etiology and suppression of CNS autoimmune diseases. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1514080"},{"key":"ref_317","doi-asserted-by":"crossref","first-page":"155654","DOI":"10.1016\/j.cyto.2021.155654","article-title":"Role of IL-6 in the commitment of T cell subsets","volume":"146","author":"Korn","year":"2021","journal-title":"Cytokine"},{"key":"ref_318","doi-asserted-by":"crossref","first-page":"e20212434","DOI":"10.1084\/jem.20212434","article-title":"Differential IL-12 signaling induces human natural killer cell activating receptor-mediated ligand-specific expansion","volume":"219","author":"Shemesh","year":"2022","journal-title":"J. Exp. Med."},{"key":"ref_319","unstructured":"Kirchhammer, N., Trefny, M.P., Natoli, M., Br\u00fccher, D., Smith, S.N., Werner, F., Koch, V., Schreiner, D., Bartoszek, E., and Buchi, M. (2021). Successful IL-12 cancer immunotherapy requires NK cell-derived CCL5 for anti-tumor DC-T cell crosstalk. bioRxiv."},{"key":"ref_320","doi-asserted-by":"crossref","first-page":"e01949","DOI":"10.7554\/eLife.01949","article-title":"T cell-intrinsic role of IL-6 signaling in primary and memory responses","volume":"3","author":"Nish","year":"2014","journal-title":"eLife"},{"key":"ref_321","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.celrep.2014.07.008","article-title":"IL-6 trans-Signaling-Dependent Rapid Development of Cytotoxic CD8+ T Cell Function","volume":"8","author":"Schanz","year":"2014","journal-title":"Cell Rep."},{"key":"ref_322","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1083\/jcb.200406136","article-title":"XBP1: A link between the unfolded protein response, lipid biosynthesis, and biogenesis of the endoplasmic reticulum","volume":"167","author":"Sriburi","year":"2004","journal-title":"J. Cell Biol."},{"key":"ref_323","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s12672-026-04715-9","article-title":"Identification of tolerogenic dendritic cells-related prognostic biomarkers in Wilms tumor via machine learning integration","volume":"17","author":"Sun","year":"2026","journal-title":"Discov. Oncol."},{"key":"ref_324","doi-asserted-by":"crossref","unstructured":"DeVito, N.C., Plebanek, M.P., Theivanthiran, B., and Hanks, B.A. (2019). Role of Tumor-Mediated Dendritic Cell Tolerization in Immune Evasion. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.02876"},{"key":"ref_325","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00262-011-1181-5","article-title":"Immune suppression in the tumor microenvironment: A role for dendritic cell-mediated tolerization of T cells","volume":"61","author":"Hurwitz","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_326","doi-asserted-by":"crossref","first-page":"eadx9864","DOI":"10.1126\/sciadv.adx9864","article-title":"Distinct thymic pDC populations promote tumor immune tolerance through complementary mechanisms","volume":"12","author":"Wang","year":"2026","journal-title":"Sci. Adv."},{"key":"ref_327","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41392-024-01979-x","article-title":"Cold and hot tumors: From molecular mechanisms to targeted therapy","volume":"9","author":"Wu","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_328","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.it.2022.04.010","article-title":"Turning cold tumors hot: From molecular mechanisms to clinical applications","volume":"43","author":"Zhang","year":"2022","journal-title":"Trends Immunol."},{"key":"ref_329","doi-asserted-by":"crossref","unstructured":"Sang, M., Ge, J., Ge, J., Tang, G., Wang, Q., Wu, J., Mao, L., Ding, X., and Zhou, X. (2025). Immune regulatory genes impact the hot\/cold tumor microenvironment, affecting cancer treatment and patient outcomes. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1382842"},{"key":"ref_330","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/s12935-022-02778-6","article-title":"CAR-T cell combination therapy: The next revolution in cancer treatment","volume":"22","author":"Tondok","year":"2022","journal-title":"Cancer Cell Int."},{"key":"ref_331","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.ccell.2024.07.002","article-title":"CAR T cell combination therapies to treat cancer","volume":"42","author":"Uslu","year":"2024","journal-title":"Cancer Cell"},{"key":"ref_332","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41392-023-01365-z","article-title":"Emerging phagocytosis checkpoints in cancer immunotherapy","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_333","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41568-025-00893-w","article-title":"Targeting phagocytosis checkpoints for cancer immunotherapy","volume":"26","author":"Veillette","year":"2026","journal-title":"Nat. Rev. Cancer"},{"key":"ref_334","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s42003-025-09331-x","article-title":"IL-21 promotes the anti-tumor effect of anti-CD47 chimeric antigen receptor macrophages in ovarian cancer","volume":"9","author":"Chen","year":"2025","journal-title":"Commun. Biol."},{"key":"ref_335","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nrd4296","article-title":"Interleukin-21: A double-edged sword with therapeutic potential","volume":"13","author":"Spolski","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_336","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/s41401-025-01652-1","article-title":"An engineered IL-21 variant is a potent antitumor candidate for antitumor immunotherapy","volume":"47","author":"Wu","year":"2026","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_337","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.chom.2011.04.006","article-title":"Trained immunity: A memory for innate host defense","volume":"9","author":"Netea","year":"2011","journal-title":"Cell Host Microbe"},{"key":"ref_338","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.immuni.2020.10.011","article-title":"The Intersection of Epigenetics and Metabolism in Trained Immunity","volume":"54","author":"Fanucchi","year":"2021","journal-title":"Immunity"},{"key":"ref_339","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.cell.2020.09.059","article-title":"Trained Immunity-Promoting Nanobiologic Therapy Suppresses Tumor Growth and Potentiates Checkpoint Inhibition","volume":"183","author":"Priem","year":"2020","journal-title":"Cell"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/16\/2672\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T08:08:20Z","timestamp":1787126900000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/16\/2672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":339,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["cancers18162672"],"URL":"https:\/\/doi.org\/10.3390\/cancers18162672","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]}}}